INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $26,849,783 | +6.9% | 1,343,833 | +15.2% | 0.01% | -14.3% |
Q3 2022 | $25,119,926 | +14.0% | 1,166,199 | +4.4% | 0.01% | +16.7% |
Q2 2022 | $22,033,057 | -18.0% | 1,117,295 | -2.3% | 0.01% | 0.0% |
Q1 2022 | $26,872,767 | -23.9% | 1,143,522 | -11.8% | 0.01% | -14.3% |
Q4 2021 | $35,308,000 | +36.6% | 1,296,198 | +38.1% | 0.01% | +16.7% |
Q3 2021 | $25,857,000 | -17.8% | 938,898 | -15.0% | 0.01% | -14.3% |
Q2 2021 | $31,451,000 | -12.0% | 1,105,091 | +5.3% | 0.01% | -12.5% |
Q1 2021 | $35,740,000 | +29.9% | 1,049,311 | +27.0% | 0.01% | +33.3% |
Q4 2020 | $27,515,000 | -31.7% | 826,536 | -34.1% | 0.01% | -45.5% |
Q3 2020 | $40,290,000 | +0.6% | 1,253,573 | -13.8% | 0.01% | -8.3% |
Q2 2020 | $40,036,000 | +117.3% | 1,453,733 | +26.5% | 0.01% | +71.4% |
Q1 2020 | $18,422,000 | -28.5% | 1,149,212 | +6.5% | 0.01% | 0.0% |
Q4 2019 | $25,766,000 | +58.9% | 1,078,965 | +17.4% | 0.01% | +40.0% |
Q3 2019 | $16,212,000 | -31.1% | 919,044 | 0.0% | 0.01% | -28.6% |
Q2 2019 | $23,527,000 | +6.7% | 919,044 | +21.1% | 0.01% | 0.0% |
Q1 2019 | $22,060,000 | +121.6% | 758,837 | 0.0% | 0.01% | +75.0% |
Q4 2018 | $9,955,000 | -29.6% | 758,837 | +8.5% | 0.00% | -20.0% |
Q3 2018 | $14,143,000 | -14.5% | 699,455 | 0.0% | 0.01% | -16.7% |
Q2 2018 | $16,542,000 | +0.8% | 699,455 | -4.1% | 0.01% | 0.0% |
Q1 2018 | $16,417,000 | -27.8% | 729,005 | 0.0% | 0.01% | -25.0% |
Q4 2017 | $22,730,000 | +37.4% | 729,005 | +37.5% | 0.01% | +33.3% |
Q3 2017 | $16,542,000 | +56.3% | 530,036 | -14.0% | 0.01% | +50.0% |
Q2 2017 | $10,582,000 | +45.2% | 616,674 | +48.2% | 0.00% | +33.3% |
Q1 2017 | $7,288,000 | +100.5% | 416,226 | +51.5% | 0.00% | +50.0% |
Q4 2016 | $3,635,000 | +8.9% | 274,782 | +14.1% | 0.00% | 0.0% |
Q3 2016 | $3,339,000 | -19.1% | 240,767 | -42.5% | 0.00% | 0.0% |
Q2 2016 | $4,127,000 | -26.6% | 418,525 | -5.6% | 0.00% | -33.3% |
Q1 2016 | $5,619,000 | -30.2% | 443,525 | 0.0% | 0.00% | -25.0% |
Q4 2015 | $8,050,000 | +265.2% | 443,525 | +273.8% | 0.00% | +300.0% |
Q3 2015 | $2,204,000 | +125.6% | 118,662 | +196.7% | 0.00% | – |
Q2 2015 | $977,000 | +17.4% | 40,000 | 0.0% | 0.00% | – |
Q1 2015 | $832,000 | – | 40,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |